| Financial Year |
March 31 2023 |
| Monetary Funds |
1,292,883,920.59 |
| Held-for-trading Financial Assets |
60,799,561.63 |
| Notes Receivable |
-- |
| Accounts Receivable |
455,073,816.67 |
| Advances to Suppliers |
27,016,830.40 |
| Other Receivables |
37,489,126.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
380,527,617.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,089,062.45 |
| Other Current Assets |
9,779,154.93 |
| Total Current Assets |
4,408,656,236.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
25,680,318.63 |
| Long-term Equity Investment |
53,883,587.61 |
| Investment Properties |
-- |
| Fixed Assetes |
2,327,483,298.27 |
| Under-construction Projects |
212,559,490.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
112,994,149.28 |
| R&D expenses |
2,327,749.96 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
811,252.82 |
| Deferred Income Tax Assets |
82,418,362.45 |
| Other Non-Current Assets |
63,451,176.15 |
| Sub-Total of Non-Current Assets |
2,985,030,638.64 |
| Total Assets |
7,393,686,875.36 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,270,280,619.90 |
| Accounts Payable |
867,898,340.15 |
| Accounts Received In Advance |
9,493,255.00 |
| Employee Compensation Payable |
174,683,705.77 |
| Taxes Payable |
135,795,439.62 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
89,412,945.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,303,819.38 |
| Other Current Liabilities |
16,862,588.66 |
| Sub-Total of Current Liabilities |
2,713,139,651.10 |
| Long-term Loans |
100,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,261,426.13 |
| Deferred Income Tax Liabilities |
24,552,869.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
311,160,452.56 |
| Total Liabilities |
3,024,300,103.66 |
| Paid-In Capital(Or Share Stock) |
895,091,926.00 |
| Capital Surplus |
1,028,094,301.43 |
| Surplus Reserve |
447,545,963.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,034,205,196.21 |
| Minority Stockholder's Interest |
-28,175,566.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,397,562,338.06 |
| Owner's Equity（Stockholder's Equity） |
4,369,386,771.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,393,686,875.36 |
